2018-2023 Global Eculizumab Drug Consumption Market Report

August 2018 | 134 pages | ID: 2C7AA33F71DEN
LP Information

Abstracts

The report requires updating with new data and is sent in 48 hours after order is placed.

In this report, LP Information covers the present scenario (with the base year being 2017) and the growth prospects of global Eculizumab Drug market for 2018-2023.
Eculizumab, sold under the trade name Soliris, is a medication used to treat paroxysmal nocturnal hemoglobinuria (PNH) and atypical hemolytic uremic syndrome (aHUS). It is a humanized monoclonal antibodyfunctioning as a terminal complement inhibitor.

Over the next five years, LPI(LP Information) projects that Eculizumab Drug will register a xx% CAGR in terms of revenue, reach US$ xx million by 2023, from US$ xx million in 2017.

This report presents a comprehensive overview, market shares, and growth opportunities of Eculizumab Drug market by product type, application, key manufacturers and key regions.

To calculate the market size, LP Information considers value and volume generated from the sales of the following segments:

Segmentation by product type:

• Plasma Exchange
• Plasma Infusion

Segmentation by application:

• PNH
• aHUS
• Other

This report also splits the market by region:

• Americas
• United States
• Canada
• Mexico
• Brazil
• APAC
• China
• Japan
• Korea
• Southeast Asia
• India
• Australia
• Europe
• Germany
• France
• UK
• Italy
• Russia
• Spain
• Middle East & Africa
• Egypt
• South Africa
• Israel
• Turkey
• GCC Countries

The report also presents the market competition landscape and a corresponding detailed analysis of the major vendor/manufacturers in the market. The key manufacturers covered in this report:

• Alexion

In addition, this report discusses the key drivers influencing market growth, opportunities, the challenges and the risks faced by key manufacturers and the market as a whole. It also analyzes key emerging trends and their impact on present and future development.

RESEARCH OBJECTIVES

• To study and analyze the global Eculizumab Drug consumption (value & volume) by key regions/countries, product type and application, history data from 2013 to 2017, and forecast to 2023.
• To understand the structure of Eculizumab Drug market by identifying its various subsegments.
• Focuses on the key global Eculizumab Drug manufacturers, to define, describe and analyze the sales volume, value, market share, market competition landscape, SWOT analysis and development plans in next few years.
• To analyze the Eculizumab Drug with respect to individual growth trends, future prospects, and their contribution to the total market.
• To share detailed information about the key factors influencing the growth of the market (growth potential, opportunities, drivers, industry-specific challenges and risks).
• To project the consumption of Eculizumab Drug submarkets, with respect to key regions (along with their respective key countries).
• To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.
• To strategically profile the key players and comprehensively analyze their growth strategies.

Contents

2018-2023 GLOBAL ECULIZUMAB DRUG CONSUMPTION MARKET REPORT

1 SCOPE OF THE REPORT

1.1 Market Introduction
1.2 Research Objectives
1.3 Years Considered
1.4 Market Research Methodology
1.5 Economic Indicators
1.6 Currency Considered

2 EXECUTIVE SUMMARY

2.1 World Market Overview
  2.1.1 Global Eculizumab Drug Consumption 2013-2023
  2.1.2 Eculizumab Drug Consumption CAGR by Region
2.2 Eculizumab Drug Segment by Type
  2.2.1 Plasma Exchange
  2.2.2 Plasma Infusion
2.3 Eculizumab Drug Consumption by Type
  2.3.1 Global Eculizumab Drug Consumption Market Share by Type (2013-2018)
  2.3.2 Global Eculizumab Drug Revenue and Market Share by Type (2013-2018)
  2.3.3 Global Eculizumab Drug Sale Price by Type (2013-2018)
2.4 Eculizumab Drug Segment by Application
  2.4.1 PNH
  2.4.2 aHUS
  2.4.3 Other
2.5 Eculizumab Drug Consumption by Application
  2.5.1 Global Eculizumab Drug Consumption Market Share by Application (2013-2018)
  2.5.2 Global Eculizumab Drug Value and Market Share by Application (2013-2018)
  2.5.3 Global Eculizumab Drug Sale Price by Application (2013-2018)

3 GLOBAL ECULIZUMAB DRUG BY PLAYERS

3.1 Global Eculizumab Drug Sales Market Share by Players
  3.1.1 Global Eculizumab Drug Sales by Players (2016-2018)
  3.1.2 Global Eculizumab Drug Sales Market Share by Players (2016-2018)
3.2 Global Eculizumab Drug Revenue Market Share by Players
  3.2.1 Global Eculizumab Drug Revenue by Players (2016-2018)
  3.2.2 Global Eculizumab Drug Revenue Market Share by Players (2016-2018)
3.3 Global Eculizumab Drug Sale Price by Players
3.4 Global Eculizumab Drug Manufacturing Base Distribution, Sales Area, Product Types by Players
  3.4.1 Global Eculizumab Drug Manufacturing Base Distribution and Sales Area by Players
  3.4.2 Players Eculizumab Drug Products Offered
3.5 Market Concentration Rate Analysis
  3.5.1 Competition Landscape Analysis
  3.5.2 Concentration Ratio (CR3, CR5 and CR10) (2016-2018)
3.6 New Products and Potential Entrants
3.7 Mergers & Acquisitions, Expansion

4 ECULIZUMAB DRUG BY REGIONS

4.1 Eculizumab Drug by Regions
  4.1.1 Global Eculizumab Drug Consumption by Regions
  4.1.2 Global Eculizumab Drug Value by Regions
4.2 Americas Eculizumab Drug Consumption Growth
4.3 APAC Eculizumab Drug Consumption Growth
4.4 Europe Eculizumab Drug Consumption Growth
4.5 Middle East & Africa Eculizumab Drug Consumption Growth

5 AMERICAS

5.1 Americas Eculizumab Drug Consumption by Countries
  5.1.1 Americas Eculizumab Drug Consumption by Countries (2013-2018)
  5.1.2 Americas Eculizumab Drug Value by Countries (2013-2018)
5.2 Americas Eculizumab Drug Consumption by Type
5.3 Americas Eculizumab Drug Consumption by Application
5.4 United States
5.5 Canada
5.6 Mexico
5.7 Key Economic Indicators of Few Americas Countries

6 APAC

6.1 APAC Eculizumab Drug Consumption by Countries
  6.1.1 APAC Eculizumab Drug Consumption by Countries (2013-2018)
  6.1.2 APAC Eculizumab Drug Value by Countries (2013-2018)
6.2 APAC Eculizumab Drug Consumption by Type
6.3 APAC Eculizumab Drug Consumption by Application
6.4 China
6.5 Japan
6.6 Korea
6.7 Southeast Asia
6.8 India
6.9 Australia
6.10 Key Economic Indicators of Few APAC Countries

7 EUROPE

7.1 Europe Eculizumab Drug by Countries
  7.1.1 Europe Eculizumab Drug Consumption by Countries (2013-2018)
  7.1.2 Europe Eculizumab Drug Value by Countries (2013-2018)
7.2 Europe Eculizumab Drug Consumption by Type
7.3 Europe Eculizumab Drug Consumption by Application
7.4 Germany
7.5 France
7.6 UK
7.7 Italy
7.8 Russia
7.9 Spain
7.10 Key Economic Indicators of Few Europe Countries

8 MIDDLE EAST & AFRICA

8.1 Middle East & Africa Eculizumab Drug by Countries
  8.1.1 Middle East & Africa Eculizumab Drug Consumption by Countries (2013-2018)
  8.1.2 Middle East & Africa Eculizumab Drug Value by Countries (2013-2018)
8.2 Middle East & Africa Eculizumab Drug Consumption by Type
8.3 Middle East & Africa Eculizumab Drug Consumption by Application
8.4 Egypt
8.5 South Africa
8.6 Israel
8.7 Turkey
8.8 GCC Countries

9 MARKET DRIVERS, CHALLENGES AND TRENDS

9.1 Market Drivers and Impact
  9.1.1 Growing Demand from Key Regions
  9.1.2 Growing Demand from Key Applications and Potential Industries
9.2 Market Challenges and Impact
9.3 Market Trends

10 MARKETING, DISTRIBUTORS AND CUSTOMER

10.1 Sales Channel
  10.1.1 Direct Marketing
  10.1.2 Indirect Marketing
10.2 Eculizumab Drug Distributors
10.3 Eculizumab Drug Customer

11 GLOBAL ECULIZUMAB DRUG MARKET FORECAST

11.1 Global Eculizumab Drug Consumption Forecast (2018-2023)
11.2 Global Eculizumab Drug Forecast by Regions
  11.2.1 Global Eculizumab Drug Forecast by Regions (2018-2023)
  11.2.2 Global Eculizumab Drug Value Forecast by Regions (2018-2023)
  11.2.3 Americas Consumption Forecast
  11.2.4 APAC Consumption Forecast
  11.2.5 Europe Consumption Forecast
  11.2.6 Middle East & Africa Consumption Forecast
11.3 Americas Forecast by Countries
  11.3.1 United States Market Forecast
  11.3.2 Canada Market Forecast
  11.3.3 Mexico Market Forecast
  11.3.4 Brazil Market Forecast
11.4 APAC Forecast by Countries
  11.4.1 China Market Forecast
  11.4.2 Japan Market Forecast
  11.4.3 Korea Market Forecast
  11.4.4 Southeast Asia Market Forecast
  11.4.5 India Market Forecast
  11.4.6 Australia Market Forecast
11.5 Europe Forecast by Countries
  11.5.1 Germany Market Forecast
  11.5.2 France Market Forecast
  11.5.3 UK Market Forecast
  11.5.4 Italy Market Forecast
  11.5.5 Russia Market Forecast
  11.5.6 Spain Market Forecast
11.6 Middle East & Africa Forecast by Countries
  11.6.1 Egypt Market Forecast
  11.6.2 South Africa Market Forecast
  11.6.3 Israel Market Forecast
  11.6.4 Turkey Market Forecast
  11.6.5 GCC Countries Market Forecast
11.7 Global Eculizumab Drug Forecast by Type
11.8 Global Eculizumab Drug Forecast by Application

12 KEY PLAYERS ANALYSIS

12.1 Alexion
  12.1.1 Company Details
  12.1.2 Eculizumab Drug Product Offered
  12.1.3 Alexion Eculizumab Drug Sales, Revenue, Price and Gross Margin (2016-2018)
  12.1.4 Main Business Overview
  12.1.5 Alexion News

13 RESEARCH FINDINGS AND CONCLUSION

List Of Tables

LIST OF TABLES AND FIGURES

Figure Picture of Eculizumab Drug
Table Product Specifications of Eculizumab Drug
Figure Eculizumab Drug Report Years Considered
Figure Market Research Methodology
Figure Global Eculizumab Drug Consumption Growth Rate 2013-2023 (K Units)
Figure Global Eculizumab Drug Value Growth Rate 2013-2023 ($ Millions)
Table Eculizumab Drug Consumption CAGR by Region 2013-2023 ($ Millions)
Figure Product Picture of Plasma Exchange
Table Major Players of Plasma Exchange
Figure Product Picture of Plasma Infusion
Table Major Players of Plasma Infusion
Table Global Consumption Sales by Type (2013-2018)
Table Global Eculizumab Drug Consumption Market Share by Type (2013-2018)
Figure Global Eculizumab Drug Consumption Market Share by Type (2013-2018)
Table Global Eculizumab Drug Revenue by Type (2013-2018) ($ million)
Table Global Eculizumab Drug Value Market Share by Type (2013-2018) ($ Millions)
Figure Global Eculizumab Drug Value Market Share by Type (2013-2018)
Table Global Eculizumab Drug Sale Price by Type (2013-2018)
Figure Eculizumab Drug Consumed in PNH
Figure Global Eculizumab Drug Market: PNH (2013-2018) (K Units)
Figure Global Eculizumab Drug Market: PNH (2013-2018) ($ Millions)
Figure Global PNH YoY Growth ($ Millions)
Figure Eculizumab Drug Consumed in aHUS
Figure Global Eculizumab Drug Market: aHUS (2013-2018) (K Units)
Figure Global Eculizumab Drug Market: aHUS (2013-2018) ($ Millions)
Figure Global aHUS YoY Growth ($ Millions)
Figure Eculizumab Drug Consumed in Other
Figure Global Eculizumab Drug Market: Other (2013-2018) (K Units)
Figure Global Eculizumab Drug Market: Other (2013-2018) ($ Millions)
Figure Global Other YoY Growth ($ Millions)
Table Global Consumption Sales by Application (2013-2018)
Table Global Eculizumab Drug Consumption Market Share by Application (2013-2018)
Figure Global Eculizumab Drug Consumption Market Share by Application (2013-2018)
Table Global Eculizumab Drug Value by Application (2013-2018)
Table Global Eculizumab Drug Value Market Share by Application (2013-2018)
Figure Global Eculizumab Drug Value Market Share by Application (2013-2018)
Table Global Eculizumab Drug Sale Price by Application (2013-2018)
Table Global Eculizumab Drug Sales by Players (2016-2018) (K Units)
Table Global Eculizumab Drug Sales Market Share by Players (2016-2018)
Figure Global Eculizumab Drug Sales Market Share by Players in 2016
Figure Global Eculizumab Drug Sales Market Share by Players in 2017
Table Global Eculizumab Drug Revenue by Players (2016-2018) ($ Millions)
Table Global Eculizumab Drug Revenue Market Share by Players (2016-2018)
Figure Global Eculizumab Drug Revenue Market Share by Players in 2016
Figure Global Eculizumab Drug Revenue Market Share by Players in 2017
Table Global Eculizumab Drug Sale Price by Players (2016-2018)
Figure Global Eculizumab Drug Sale Price by Players in 2017
Table Global Eculizumab Drug Manufacturing Base Distribution and Sales Area by Players
Table Players Eculizumab Drug Products Offered
Table Eculizumab Drug Concentration Ratio (CR3, CR5 and CR10) (2016-2018)
Table Global Eculizumab Drug Consumption by Regions 2013-2018 (K Units)
Table Global Eculizumab Drug Consumption Market Share by Regions 2013-2018
Figure Global Eculizumab Drug Consumption Market Share by Regions 2013-2018
Table Global Eculizumab Drug Value by Regions 2013-2018 ($ Millions)
Table Global Eculizumab Drug Value Market Share by Regions 2013-2018
Figure Global Eculizumab Drug Value Market Share by Regions 2013-2018
Figure Americas Eculizumab Drug Consumption 2013-2018 (K Units)
Figure Americas Eculizumab Drug Value 2013-2018 ($ Millions)
Figure APAC Eculizumab Drug Consumption 2013-2018 (K Units)
Figure APAC Eculizumab Drug Value 2013-2018 ($ Millions)
Figure Europe Eculizumab Drug Consumption 2013-2018 (K Units)
Figure Europe Eculizumab Drug Value 2013-2018 ($ Millions)
Figure Middle East & Africa Eculizumab Drug Consumption 2013-2018 (K Units)
Figure Middle East & Africa Eculizumab Drug Value 2013-2018 ($ Millions)
Table Americas Eculizumab Drug Consumption by Countries (2013-2018) (K Units)
Table Americas Eculizumab Drug Consumption Market Share by Countries (2013-2018)
Figure Americas Eculizumab Drug Consumption Market Share by Countries in 2017
Table Americas Eculizumab Drug Value by Countries (2013-2018) ($ Millions)
Table Americas Eculizumab Drug Value Market Share by Countries (2013-2018)
Figure Americas Eculizumab Drug Value Market Share by Countries in 2017
Table Americas Eculizumab Drug Consumption by Type (2013-2018) (K Units)
Table Americas Eculizumab Drug Consumption Market Share by Type (2013-2018)
Figure Americas Eculizumab Drug Consumption Market Share by Type in 2017
Table Americas Eculizumab Drug Consumption by Application (2013-2018) (K Units)
Table Americas Eculizumab Drug Consumption Market Share by Application (2013-2018)
Figure Americas Eculizumab Drug Consumption Market Share by Application in 2017
Figure United States Eculizumab Drug Consumption Growth 2013-2018 (K Units)
Figure United States Eculizumab Drug Value Growth 2013-2018 ($ Millions)
Figure Canada Eculizumab Drug Consumption Growth 2013-2018 (K Units)
Figure Canada Eculizumab Drug Value Growth 2013-2018 ($ Millions)
Figure Mexico Eculizumab Drug Consumption Growth 2013-2018 (K Units)
Figure Mexico Eculizumab Drug Value Growth 2013-2018 ($ Millions)
Table APAC Eculizumab Drug Consumption by Countries (2013-2018) (K Units)
Table APAC Eculizumab Drug Consumption Market Share by Countries (2013-2018)
Figure APAC Eculizumab Drug Consumption Market Share by Countries in 2017
Table APAC Eculizumab Drug Value by Countries (2013-2018) ($ Millions)
Table APAC Eculizumab Drug Value Market Share by Countries (2013-2018)
Figure APAC Eculizumab Drug Value Market Share by Countries in 2017
Table APAC Eculizumab Drug Consumption by Type (2013-2018) (K Units)
Table APAC Eculizumab Drug Consumption Market Share by Type (2013-2018)
Figure APAC Eculizumab Drug Consumption Market Share by Type in 2017
Table APAC Eculizumab Drug Consumption by Application (2013-2018) (K Units)
Table APAC Eculizumab Drug Consumption Market Share by Application (2013-2018)
Figure APAC Eculizumab Drug Consumption Market Share by Application in 2017
Figure China Eculizumab Drug Consumption Growth 2013-2018 (K Units)
Figure China Eculizumab Drug Value Growth 2013-2018 ($ Millions)
Figure Japan Eculizumab Drug Consumption Growth 2013-2018 (K Units)
Figure Japan Eculizumab Drug Value Growth 2013-2018 ($ Millions)
Figure Korea Eculizumab Drug Consumption Growth 2013-2018 (K Units)
Figure Korea Eculizumab Drug Value Growth 2013-2018 ($ Millions)
Figure Southeast Asia Eculizumab Drug Consumption Growth 2013-2018 (K Units)
Figure Southeast Asia Eculizumab Drug Value Growth 2013-2018 ($ Millions)
Figure India Eculizumab Drug Consumption Growth 2013-2018 (K Units)
Figure India Eculizumab Drug Value Growth 2013-2018 ($ Millions)
Figure Australia Eculizumab Drug Consumption Growth 2013-2018 (K Units)
Figure Australia Eculizumab Drug Value Growth 2013-2018 ($ Millions)
Table Europe Eculizumab Drug Consumption by Countries (2013-2018) (K Units)
Table Europe Eculizumab Drug Consumption Market Share by Countries (2013-2018)
Figure Europe Eculizumab Drug Consumption Market Share by Countries in 2017
Table Europe Eculizumab Drug Value by Countries (2013-2018) ($ Millions)
Table Europe Eculizumab Drug Value Market Share by Countries (2013-2018)
Figure Europe Eculizumab Drug Value Market Share by Countries in 2017
Table Europe Eculizumab Drug Consumption by Type (2013-2018) (K Units)
Table Europe Eculizumab Drug Consumption Market Share by Type (2013-2018)
Figure Europe Eculizumab Drug Consumption Market Share by Type in 2017
Table Europe Eculizumab Drug Consumption by Application (2013-2018) (K Units)
Table Europe Eculizumab Drug Consumption Market Share by Application (2013-2018)
Figure Europe Eculizumab Drug Consumption Market Share by Application in 2017
Figure Germany Eculizumab Drug Consumption Growth 2013-2018 (K Units)
Figure Germany Eculizumab Drug Value Growth 2013-2018 ($ Millions)
Figure France Eculizumab Drug Consumption Growth 2013-2018 (K Units)
Figure France Eculizumab Drug Value Growth 2013-2018 ($ Millions)
Figure UK Eculizumab Drug Consumption Growth 2013-2018 (K Units)
Figure UK Eculizumab Drug Value Growth 2013-2018 ($ Millions)
Figure Italy Eculizumab Drug Consumption Growth 2013-2018 (K Units)
Figure Italy Eculizumab Drug Value Growth 2013-2018 ($ Millions)
Figure Russia Eculizumab Drug Consumption Growth 2013-2018 (K Units)
Figure Russia Eculizumab Drug Value Growth 2013-2018 ($ Millions)
Figure Spain Eculizumab Drug Consumption Growth 2013-2018 (K Units)
Figure Spain Eculizumab Drug Value Growth 2013-2018 ($ Millions)
Table Middle East & Africa Eculizumab Drug Consumption by Countries (2013-2018) (K Units)
Table Middle East & Africa Eculizumab Drug Consumption Market Share by Countries (2013-2018)
Figure Middle East & Africa Eculizumab Drug Consumption Market Share by Countries in 2017
Table Middle East & Africa Eculizumab Drug Value by Countries (2013-2018) ($ Millions)
Table Middle East & Africa Eculizumab Drug Value Market Share by Countries (2013-2018)
Figure Middle East & Africa Eculizumab Drug Value Market Share by Countries in 2017
Table Middle East & Africa Eculizumab Drug Consumption by Type (2013-2018) (K Units)
Table Middle East & Africa Eculizumab Drug Consumption Market Share by Type (2013-2018)
Figure Middle East & Africa Eculizumab Drug Consumption Market Share by Type in 2017
Table Middle East & Africa Eculizumab Drug Consumption by Application (2013-2018) (K Units)
Table Middle East & Africa Eculizumab Drug Consumption Market Share by Application (2013-2018)
Figure Middle East & Africa Eculizumab Drug Consumption Market Share by Application in 2017
Figure Egypt Eculizumab Drug Consumption Growth 2013-2018 (K Units)
Figure Egypt Eculizumab Drug Value Growth 2013-2018 ($ Millions)
Figure South Africa Eculizumab Drug Consumption Growth 2013-2018 (K Units)
Figure South Africa Eculizumab Drug Value Growth 2013-2018 ($ Millions)
Figure Israel Eculizumab Drug Consumption Growth 2013-2018 (K Units)
Figure Israel Eculizumab Drug Value Growth 2013-2018 ($ Millions)
Figure Turkey Eculizumab Drug Consumption Growth 2013-2018 (K Units)
Figure Turkey Eculizumab Drug Value Growth 2013-2018 ($ Millions)
Figure GCC Countries Eculizumab Drug Consumption Growth 2013-2018 (K Units)
Figure GCC Countries Eculizumab Drug Value Growth 2013-2018 ($ Millions)
Table Eculizumab Drug Distributors List
Table Eculizumab Drug Customer List
Figure Global Eculizumab Drug Consumption Growth Rate Forecast (2018-2023) (K Units)
Figure Global Eculizumab Drug Value Growth Rate Forecast (2018-2023) ($ Millions)
Table Global Eculizumab Drug Consumption Forecast by Countries (2018-2023) (K Units)
Table Global Eculizumab Drug Consumption Market Forecast by Regions
Table Global Eculizumab Drug Value Forecast by Countries (2018-2023) ($ Millions)
Table Global Eculizumab Drug Value Market Share Forecast by Regions
Figure Americas Eculizumab Drug Consumption 2018-2023 (K Units)
Figure Americas Eculizumab Drug Value 2018-2023 ($ Millions)
Figure APAC Eculizumab Drug Consumption 2018-2023 (K Units)
Figure APAC Eculizumab Drug Value 2018-2023 ($ Millions)
Figure Europe Eculizumab Drug Consumption 2018-2023 (K Units)
Figure Europe Eculizumab Drug Value 2018-2023 ($ Millions)
Figure Middle East & Africa Eculizumab Drug Consumption 2018-2023 (K Units)
Figure Middle East & Africa Eculizumab Drug Value 2018-2023 ($ Millions)
Figure United States Eculizumab Drug Consumption 2018-2023 (K Units)
Figure United States Eculizumab Drug Value 2018-2023 ($ Millions)
Figure Canada Eculizumab Drug Consumption 2018-2023 (K Units)
Figure Canada Eculizumab Drug Value 2018-2023 ($ Millions)
Figure Mexico Eculizumab Drug Consumption 2018-2023 (K Units)
Figure Mexico Eculizumab Drug Value 2018-2023 ($ Millions)
Figure Brazil Eculizumab Drug Consumption 2018-2023 (K Units)
Figure Brazil Eculizumab Drug Value 2018-2023 ($ Millions)
Figure China Eculizumab Drug Consumption 2018-2023 (K Units)
Figure China Eculizumab Drug Value 2018-2023 ($ Millions)
Figure Japan Eculizumab Drug Consumption 2018-2023 (K Units)
Figure Japan Eculizumab Drug Value 2018-2023 ($ Millions)
Figure Korea Eculizumab Drug Consumption 2018-2023 (K Units)
Figure Korea Eculizumab Drug Value 2018-2023 ($ Millions)
Figure Southeast Asia Eculizumab Drug Consumption 2018-2023 (K Units)
Figure Southeast Asia Eculizumab Drug Value 2018-2023 ($ Millions)
Figure India Eculizumab Drug Consumption 2018-2023 (K Units)
Figure India Eculizumab Drug Value 2018-2023 ($ Millions)
Figure Australia Eculizumab Drug Consumption 2018-2023 (K Units)
Figure Australia Eculizumab Drug Value 2018-2023 ($ Millions)
Figure Germany Eculizumab Drug Consumption 2018-2023 (K Units)
Figure Germany Eculizumab Drug Value 2018-2023 ($ Millions)
Figure France Eculizumab Drug Consumption 2018-2023 (K Units)
Figure France Eculizumab Drug Value 2018-2023 ($ Millions)
Figure UK Eculizumab Drug Consumption 2018-2023 (K Units)
Figure UK Eculizumab Drug Value 2018-2023 ($ Millions)
Figure Italy Eculizumab Drug Consumption 2018-2023 (K Units)
Figure Italy Eculizumab Drug Value 2018-2023 ($ Millions)
Figure Russia Eculizumab Drug Consumption 2018-2023 (K Units)
Figure Russia Eculizumab Drug Value 2018-2023 ($ Millions)
Figure Spain Eculizumab Drug Consumption 2018-2023 (K Units)
Figure Spain Eculizumab Drug Value 2018-2023 ($ Millions)
Figure Egypt Eculizumab Drug Consumption 2018-2023 (K Units)
Figure Egypt Eculizumab Drug Value 2018-2023 ($ Millions)
Figure South Africa Eculizumab Drug Consumption 2018-2023 (K Units)
Figure South Africa Eculizumab Drug Value 2018-2023 ($ Millions)
Figure Israel Eculizumab Drug Consumption 2018-2023 (K Units)
Figure Israel Eculizumab Drug Value 2018-2023 ($ Millions)
Figure Turkey Eculizumab Drug Consumption 2018-2023 (K Units)
Figure Turkey Eculizumab Drug Value 2018-2023 ($ Millions)
Figure GCC Countries Eculizumab Drug Consumption 2018-2023 (K Units)
Figure GCC Countries Eculizumab Drug Value 2018-2023 ($ Millions)
Table Global Eculizumab Drug Consumption Forecast by Type (2018-2023) (K Units)
Table Global Eculizumab Drug Consumption Market Share Forecast by Type (2018-2023)
Table Global Eculizumab Drug Value Forecast by Type (2018-2023) ($ Millions)
Table Global Eculizumab Drug Value Market Share Forecast by Type (2018-2023)
Table Global Eculizumab Drug Consumption Forecast by Application (2018-2023) (K Units)
Table Global Eculizumab Drug Consumption Market Share Forecast by Application (2018-2023)
Table Global Eculizumab Drug Value Forecast by Application (2018-2023) ($ Millions)
Table Global Eculizumab Drug Value Market Share Forecast by Application (2018-2023)
Table Alexion Basic Information, Manufacturing Base, Sales Area and Its Competitors
Table Alexion Eculizumab Drug Sales, Revenue, Price and Gross Margin (2016-2018)
Figure Alexion Eculizumab Drug Market Share (2016-2018)